88 related articles for article (PubMed ID: 24507063)
1. Generation and characterization of polyclonal antibodies against mouse T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory domain by DNA-based immunization.
Gao Y; Cui J; He W; Yue J; Yu D; Cai L; Xu H; Yang C; Chen ZK; Zhou H
Transplant Proc; 2014; 46(1):260-5. PubMed ID: 24507063
[TBL] [Abstract][Full Text] [Related]
2. TX99 Is a Neutralizing Monoclonal Antibody Against Mouse TIGIT.
Nakamura Y; Naito K; Yamashita-Kanemaru Y; Komori D; Hirochika R; Shibuya A; Shibuya K
Monoclon Antib Immunodiagn Immunother; 2018 Apr; 37(2):105-109. PubMed ID: 29648914
[TBL] [Abstract][Full Text] [Related]
3. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells.
Yu X; Harden K; Gonzalez LC; Francesco M; Chiang E; Irving B; Tom I; Ivelja S; Refino CJ; Clark H; Eaton D; Grogan JL
Nat Immunol; 2009 Jan; 10(1):48-57. PubMed ID: 19011627
[TBL] [Abstract][Full Text] [Related]
4. TgMab-2: An Anti-human T Cell Immunoglobulin and Immunoreceptor Tyrosine-Based Inhibitory Motif Domain Monoclonal Antibody for Immunocytochemistry.
Saito M; Suzuki H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Jun; 41(3):157-162. PubMed ID: 35736625
[TBL] [Abstract][Full Text] [Related]
5. Expression of T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain on CD4
Kurita M; Yoshihara Y; Ishiuji Y; Chihara M; Ishiji T; Asahina A; Yanaba K
J Dermatol; 2019 Jan; 46(1):37-42. PubMed ID: 30402886
[TBL] [Abstract][Full Text] [Related]
6. Synthetic studies on the extracellular domain of the T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain (TIGIT) using Trt-K
Iwamoto N; Sasaki J; Ohno S; Aoki K; Usui Y; Inuki S; Ohno H; Oishi S
Bioorg Med Chem; 2024 Feb; 99():117585. PubMed ID: 38219557
[TBL] [Abstract][Full Text] [Related]
7. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917
[TBL] [Abstract][Full Text] [Related]
8. Gene of the month: T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT).
Bolm L; Petruch N; Sivakumar S; Annels NE; Frampton AE
J Clin Pathol; 2022 Apr; 75(4):217-221. PubMed ID: 35058314
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of signal regulatory protein alpha and T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibition motif domain expression in undifferentiated pleomorphic sarcoma.
Ishihara S; Iwasaki T; Kohashi K; Kawaguchi K; Toda Y; Fujiwara T; Setsu N; Endo M; Matsumoto Y; Nakashima Y; Oda Y
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2425-2436. PubMed ID: 35737088
[TBL] [Abstract][Full Text] [Related]
10. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells.
Lanier LL; Corliss BC; Wu J; Leong C; Phillips JH
Nature; 1998 Feb; 391(6668):703-7. PubMed ID: 9490415
[TBL] [Abstract][Full Text] [Related]
11. T-cell Ig and ITIM domain regulates natural killer cell activation in murine acute viral hepatitis.
Bi J; Zhang Q; Liang D; Xiong L; Wei H; Sun R; Tian Z
Hepatology; 2014 May; 59(5):1715-25. PubMed ID: 24319005
[TBL] [Abstract][Full Text] [Related]
12. Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic Fc-active TIGIT antibodies.
Hasan MF; Campbell AR; Croom-Perez TJ; Oyer JL; Dieffenthaller TA; Robles-Carrillo LD; Cash CA; Eloriaga JE; Kumar S; Andersen BW; Naeimi Kararoudi M; Tullius BP; Lee DA; Copik AJ
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38081778
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of polyclonal anti-human nephrin antibodies induced by genetic immunization using nephrin cDNA.
Aoyama T; Kamata K; Yamanaka N; Takeuchi Y; Higashihara M; Kato S
Nephrol Dial Transplant; 2006 Apr; 21(4):1073-81. PubMed ID: 16431884
[TBL] [Abstract][Full Text] [Related]
14. Involvement of TIGIT in Natural Killer Cell Exhaustion and Immune Escape in Patients and Mouse Model With Liver Echinococcus multilocularis Infection.
Zhang C; Wang H; Li J; Hou X; Li L; Wang W; Shi Y; Li D; Li L; Zhao Z; Li L; Aji T; Lin R; Shao Y; Vuitton DA; Tian Z; Sun H; Wen H
Hepatology; 2021 Dec; 74(6):3376-3393. PubMed ID: 34192365
[TBL] [Abstract][Full Text] [Related]
15. TIGIT-Fc Promotes Antitumor Immunity.
Shen X; Fu W; Wei Y; Zhu J; Yu Y; Lei C; Zhao J; Hu S
Cancer Immunol Res; 2021 Sep; 9(9):1088-1097. PubMed ID: 34244300
[TBL] [Abstract][Full Text] [Related]
16. Treatment of murine lupus with TIGIT-Ig.
Liu S; Sun L; Wang C; Cui Y; Ling Y; Li T; Lin F; Fu W; Ding M; Zhang S; Lei C; Hu S
Clin Immunol; 2019 Jun; 203():72-80. PubMed ID: 31005675
[TBL] [Abstract][Full Text] [Related]
17. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.
Westgaard IH; Berg SF; Vaage JT; Wang LL; Yokoyama WM; Dissen E; Fossum S
J Leukoc Biol; 2004 Dec; 76(6):1200-6. PubMed ID: 15356098
[TBL] [Abstract][Full Text] [Related]
18. Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.
Mackel AM; Craddock GR; Warr GW; DeLuca D; Marchalonis JJ
J Immunol; 1983 Sep; 131(3):1582-90. PubMed ID: 6350458
[TBL] [Abstract][Full Text] [Related]
19. Construction of a recombinant plasmid harbouring the glyceraldenyde-3-phosphate dehydrogenase gene of periodic Brugia malayi and observation on DNA immunity.
Fang Z; Tong H; Zhang S; Fang H; Lu S; Xu B
Indian J Med Microbiol; 2012; 30(2):193-7. PubMed ID: 22664436
[TBL] [Abstract][Full Text] [Related]
20. Recognition of nectin-2 by the natural killer cell receptor T cell immunoglobulin and ITIM domain (TIGIT).
Deuss FA; Gully BS; Rossjohn J; Berry R
J Biol Chem; 2017 Jul; 292(27):11413-11422. PubMed ID: 28515320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
